North CarolinaHealthy Living Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Healthy Living are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Achieved Benchmark or Better
Measure Estimate Benchmark Distance to Benchmark
Adults age 65 and over who received an influenza vaccination in the last flu season 71.1 70.3 Achieved: 1% better
Home health care patients whose ability to walk or move around improved 72.0 71.5 Achieved: 1% better
Home health care patients whose pain when moving around decreased 73.9 73.8 -0.2%
Home health care patients whose ability to get in and out of bed improved 70.0 70.3 0.4%
Hospital patients who received influenza vaccination 95.3 97.0 1.8%
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine 94.5 96.4 1.9%
Hospital patients who received pneumococcal immunization 95.0 97.2 2.2%
Children ages 19-35 months who received 1 or more doses of varicella vaccine 93.6 95.7 2.2%
Adults who received a blood cholesterol measurement in the last 5 years 80.1 82.3 2.6%
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine 93.3 96.4 3.2%
Home health patients who had improvement in upper body dressing 74.8 77.4 3.3%
Home health care patients whose bathing improved 72.8 75.4 3.4%
Home health care patients whose shortness of breath decreased 74.3 77.0 3.6%
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years 92.1 95.9 4.0%
Adults age 65 and over who ever received pneumococcal vaccination 75.0 78.7 4.7%
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine 86.0 90.6 5.1%
Long-stay nursing home residents who were assessed for pneumococcal vaccination 92.8 98.0 5.3%
Home health care patients who stayed at home after an episode of home health care 73.1 77.5 5.7%
Home health patients who had influenza vaccination during flu season 79.9 84.8 5.8%
Long-stay nursing home patients who were assessed and appropriately given the seasonal influenza vaccine 88.2 94.1 6.3%
Children ages 19-35 months who received 3 or more doses of polio vaccine 91.0 97.3 6.5%
Short-stay nursing home residents who were assessed for pneumococcal vaccination 88.5 95.3 7.1%
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years 87.0 95.2 8.6%
Short-stay nursing home patients who had flu vaccination appropriately given 84.5 92.9 9.0%
Measures That Are Close to Benchmark
Measure Estimate Benchmark Distance to Benchmark
Home health patients who had pneumococcal polysaccharide vaccination 76.7 86.1 10.9%
Adults ages 18-64 at high risk (e.g., COPD) who received an influenza vaccination in the last flu season 42.0 47.8 12.1%
Adults ages 18-64 at high risk (e.g., COPD) who ever received pneumococcal vaccination 37.9 44.8 15.4%
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine 77.7 96.2 19.2%
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine 74.2 95.4 22.2%
Cervical cancer diagnosed at advanced stage (all invasive tumors) per 100,000 women age 20 and over 9.7 7.6 28.3%
Breast cancer diagnosed at advanced stage (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and over 93.5 72.8 28.5%
Short-stay nursing home residents with moderate to severe pain 14.8 10.8 36.8%
Colorectal cancer diagnosed at advanced stage (tumors diagnosed at regional or distant stage) per 100,000 population age 50 and over 65.1 47.2 38.0%
Long-stay nursing home residents with physical restraints 0.3 0.2 43.5%
Long-stay nursing home residents with too much weight loss 8.0 5.4 48.5%
Measures That Are Far From Benchmark
Measure Estimate Benchmark Distance to Benchmark
Long-stay nursing home residents whose need for help with daily activities increased 17.8 10.6 67.6%
Long-stay nursing home residents whose ability to move independently worsened 24.7 13.7 79.8%
Long-stay nursing home residents with moderate to severe pain 9.1 4.7 93.0%
Low-risk, long-stay nursing home residents with loss of control of bowels or bladder 48.7 16.7 191.6%
Measures With No Available Benchmark Information or Supplemental Measures
Measure Estimate Benchmark Distance to Benchmark
Children ages 19-35 months who received full series Haemophilus influenzae type B 85.6
Children ages 19-35 months who received 4 or more doses of pneumococcal conjugate vaccine 83.8
Composite measure: Children ages 19-35 months who received all recommended vaccines 77.8
Adolescent aged 13-15 years who received 3 or more doses of human papillomavirus (HPV) vaccine 33.0
Adolescents ages 13-15 years (excluding adolescents who have had varicella) vaccinated with at least 2 doses of varicella 78.5
Adolescent ages 16-17 years who received 3 or more doses of human papillomavirus (HPV) vaccine 38.1